HOME >> BIOLOGY >> NEWS
New threat to commercial fishing

Commercial fishing practices can reduce genetic diversity in fish populations, possibly threatening their productivity and adaptability to environmental change, new research has found.

An Australian zoologist now at the University of Melbourne, along with colleagues from the United Kingdom and New Zealand, was the first to record a decline in the genetic diversity of a commercially exploited marine species. Their findings, published in the latest volume of the Proceedings of the National Academy of Sciences, shout a warning that could force a rethink to current fisheries management and the research focus into sustainable fishing.

Dr Greg Adcock analysed the DNA found in scales preserved from two populations of New Zealand snapper collected from the 1950s to 1998. One population had been commercially fished since the late 1800s. The other was a 'virgin' population, being subjected to subsistence and recreational fishing only until the scale collection began.

Adcock and colleagues found that the 'virgin' population from Tasman Bay on New Zealand's South Island had suffered an unexpected decline in genetic diversity, starting from the time it began to be commercially exploited in the 1950s.

The other population, from the North Island's Hauraki Bay, showed no decline in genetic diversity in the nearly 50 years to 1998.

The paper reports that the Tasman Bay's effective population size (the number of fish in the population capable of breeding) is100,000 times fewer than its total number, and several orders of magnitude lower than expected.

"In Tasman Bay, commercial fishing has often reduced total numbers to as low as about one million. This leaves only a few hundred fish to contribute to the next generation, a dangerously low genetic base from which to sustain a population," says Adcock.

"With a high effective population you can retain a large amount of rare genetic variation. Such variation is lost as numbers
'"/>

Contact: Jason Major
jmajor@unimelb.edu.au
61-3-8344-0181
University of Melbourne
13-Aug-2002


Page: 1 2 3

Related biology news :

1. Scientists decipher genetic code of biothreat pathogen
2. Identifying tick genes could halt disease, bioterrorism threat
3. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
4. Increasing international insect threat to stored food
5. Report outlines steps needed to lessen smallpox threat
6. Computer model shows increased US threat from soybean rust
7. Danger spots identified for threatened grizzly bear
8. 51 globally threatened species get new lease on life in the Caucasus
9. Disease threatens cucumbers, pumpkins, and other vine crops
10. Urban runoff poses increased health threat for surfers, other beach users, UCI study shows
11. City rain run-off poses threat to coastal water users

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New threat commercial fishing

(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/26/2015)... ReliantHeart, Inc., an innovative supplier of advanced mechanical ... transit-time flow measurement solutions, are collaborating on a miniature ... the HeartAssist5® Left Ventricular Assist Device (LVAD). ... and peace of mind. , The Transonic flow ... 1/6th of the power required by earlier flow board ...
(Date:3/25/2015)... 26, 2015 Agnition announced today that ... American Farmer, airing for the first time at 7:30 ... American Farmer will explore the extremely important role soil ... with a patented Microbial Catalyst™ technology that enhances soil ... The segment will air again on April 28. , ...
(Date:3/25/2015)... (PRWEB) March 25, 2015 Laboratory ... Top-Loading Balances and Analytical Balances to get best-performing ... line of weighing balances from the trusted brand ... Balances increase your efficiency by providing a ... of samples. Weighing modes include parts counting, percent ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
Breaking Biology Technology:LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: